Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2025-08-08 Capital/Financing Update
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
第3次庫藏股基本資料
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the company's share buyback program, including specifics such as the number of shares to be repurchased, the purpose of the buyback (transfer to employees), board resolutions, pricing, and regulatory compliance statements. It includes procedural details and financial limits related to the buyback but does not contain financial statements or earnings data. The document is not a report of financial results or an annual/interim report but rather an update on capital structure activity. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is under 5,000 characters and contains substantive content about the buyback, so it is not merely an announcement of a report publication or a regulatory filing. Hence, the classification is CAP with high confidence.
2025-08-08 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」， 公告期間：114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the company's name change from '中化投資控股股份有限公司' to '中化控股股份有限公司'. It includes details such as the approval date, shareholder meeting resolution date, and regulatory approval number. There is no financial data, no report attached or referenced, and the document is under 5,000 characters. This is a regulatory announcement about a corporate action (name change), not a financial report or detailed management information. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-08-08 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」， 公告期間：114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement (898 characters) about a company name change from '中化投資控股股份有限公司' to '中化控股股份有限公司'. It includes details such as approval dates, shareholder meeting resolution date, and regulatory approval number. There is no financial data, no report attached or referenced as being published, and no detailed financial or management discussion. The document is a regulatory announcement about a corporate action (name change) rather than a financial report or management information. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-08-07 Chinese
114年07月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and stock ownership information of company insiders, including directors, managers, and related parties. It provides data on shares held, changes in holdings, and classifications of ownership types. There is no indication of financial statements, earnings data, management discussion, or regulatory certifications. The content is focused on insider share transactions and holdings, which aligns with reporting of personal share transactions by company directors and executives. The document length is over 10,000 characters, indicating it is a substantive report rather than a brief announcement. Therefore, the document is best classified as a Director's Dealing report.
2025-08-06 Chinese
114年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, managers, and major shareholders. It focuses on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. The content matches the description of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document length is 2675 characters, which is consistent with a detailed insider shareholding disclosure rather than a full financial report or announcement. There is no indication of it being an announcement of a report or a certification. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2025-08-06 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」， 公告期間：114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the company's name change from '中化投資控股股份有限公司' to '中化控股股份有限公司'. It includes details such as the approval date, shareholder meeting resolution date, and regulatory approval number. There is no financial data, no report attached or referenced, and no indication of a meeting or voting results beyond the name change approval. The document is essentially a regulatory announcement about a corporate name change, which fits best under Regulatory Filings (RNS) as it does not match any other specific category like management changes or capital changes.
2025-08-06 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.